Aegis Capital Comments on Inovio (INO) Following Q2 Results; Cash Position Remains 'Solid'

Go back to Aegis Capital Comments on Inovio (INO) Following Q2 Results; Cash Position Remains 'Solid'
INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) Delayed: 1.21 +0.06 (5.22%)
Previous Close $1.15    52 Week High $11.69 
Open $1.15    52 Week Low $4.50 
Day High $1.25    P/E N/A 
Day Low $1.15    EPS $-0.28 
Volume 2,720,276